Retatrutide vs Semaglutide vs Tirzepatide: Which GLP-1 Is Best?
The GLP-1 landscape is evolving fast. Semaglutide changed the game. Tirzepatide raised the bar. Now retatrutide is rewriting the rules entirely — with the highest weight loss results ever seen in clinical trials. Here's how all three compare, what's available now, and whether you should wait or start today.
Updated April 2026 · Based on published NEJM trials (STEP, SURMOUNT, TRIUMPH) · All data from clinical studies
Quick Answer: Which Should You Choose?
Choose Semaglutide if:
› You want the most affordable option
› You want oral pill or injection choice
› You want proven long-term safety data
› Available NOW from $179/mo
Choose Tirzepatide if:
› You want stronger weight loss results
› You've plateaued on semaglutide
› You want the best available option
› Available NOW from $199/mo
Consider Retatrutide if:
› You want maximum possible weight loss
› You're OK waiting for FDA approval
› You want the most advanced option
› ⏳ Expected late 2026–early 2027
The Evolution: From One Receptor to Three
Think of it like upgrading from a bicycle to a car to a jet. Each generation of GLP-1 medication targets more hormonal pathways, producing greater results:
💊
Semaglutide
Generation 1 · Single-action
~15%
body weight loss
✅ AVAILABLE NOW
💊💊
Tirzepatide
Generation 2 · Dual-action
~22.5%
body weight loss
✅ AVAILABLE NOW
💊💊💊
Retatrutide
Generation 3 · Triple-action
~29%
body weight loss
⏳ COMING 2026-2027
Head-to-Head Comparison: Every Detail
The Real Question: Should You Wait for Retatrutide?
This is what everyone wants to know. Here's the honest answer:
🟢 No. Start now. Here's why:
Every month matters. If you start semaglutide or tirzepatide today, you could lose 15-50+ pounds by the time retatrutide becomes available. That's life-changing progress you'd miss by waiting.
Retatrutide will be expensive. Brand-name launch pricing will likely be $1,000+ per month. Compounded versions won't be available immediately. Meanwhile, compounded semaglutide starts at $179/month right now.
You can switch later. Starting semaglutide or tirzepatide doesn't lock you in. When retatrutide launches, you can transition under medical guidance — with a head start on your weight loss journey.
Approval isn't guaranteed. While Phase 3 results look excellent, FDA approval is never 100% certain until it happens. Don't put your health on hold for a maybe.
Start Today With What's Available
While you wait for retatrutide, these are the top-rated providers offering semaglutide and tirzepatide online:
Frequently Asked Questions
Which is better: retatrutide, semaglutide, or tirzepatide?
For maximum weight loss, retatrutide shows the best results (up to 29%) — but it's not yet available. Among medications you can get today, tirzepatide produces greater weight loss (15-22%) than semaglutide (12-17%). The best choice depends on your needs, budget, and provider options. Compare providers →
How much more weight can you lose on retatrutide vs Ozempic?
Roughly double. Semaglutide (Ozempic/Wegovy) averages about 15% body weight loss. Retatrutide achieved up to 29% in trials. For a 250-pound person, that's about 37 lbs on semaglutide vs 72 lbs on retatrutide.
Should I wait for retatrutide or start semaglutide now?
Don't wait. Retatrutide likely won't be available until late 2026 or early 2027, and it will be expensive at launch. Starting semaglutide or tirzepatide now means you could lose 15-22% of your body weight in the meantime. You can always switch later. See providers available today →
Can I switch from semaglutide to retatrutide when it's available?
Yes — once retatrutide is FDA approved, switching will likely be possible under medical guidance. Many patients are expected to consider upgrading, especially those who've plateaued on current medications.
Will retatrutide be more expensive?
Almost certainly. Based on Eli Lilly's Mounjaro/Zepbound pricing ($1,079-1,086/month), brand-name retatrutide will likely cost $1,000-1,500/month or more. Compounded semaglutide ($179-299/month) and tirzepatide ($199-399/month) are far more affordable right now.
Is retatrutide safer than semaglutide or tirzepatide?
All three share similar side effects — mainly nausea, diarrhea, and constipation. Semaglutide and tirzepatide have more extensive real-world safety data from years of use. Retatrutide's long-term safety profile is still being established through ongoing Phase 3 trials.
Don't Wait — Start Your Journey Today
Retatrutide is coming — but semaglutide and tirzepatide are here now. Every month you wait is a month of results you're missing.
Compare All GLP-1 Providers →
Medical Disclaimer: Retatrutide is an investigational medication not yet approved by the FDA. This comparison is based on published clinical trial data and is for educational purposes only. Individual results vary. Compounded medications are not FDA-approved as finished products. Always consult a licensed healthcare provider before starting any weight loss medication.
